Market Closed -
Bombay S.E.
11:00:59 21/06/2024 BST
|
5-day change
|
1st Jan Change
|
116.4
INR
|
-1.06%
|
|
-0.13%
|
-7.77%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,102
|
578.9
|
448.4
|
1,738
|
3,310
|
4,474
|
Enterprise Value (EV)
1 |
1,394
|
887.1
|
786.3
|
1,991
|
3,528
|
4,773
|
P/E ratio
|
33.1
x
|
11.1
x
|
6.38
x
|
11.1
x
|
13.1
x
|
26.2
x
|
Yield
|
0.42%
|
0.79%
|
1.02%
|
0.4%
|
0.28%
|
0.21%
|
Capitalization / Revenue
|
0.33
x
|
0.13
x
|
0.11
x
|
0.35
x
|
0.41
x
|
0.6
x
|
EV / Revenue
|
0.42
x
|
0.2
x
|
0.19
x
|
0.41
x
|
0.43
x
|
0.64
x
|
EV / EBITDA
|
10.3
x
|
5.34
x
|
3.75
x
|
6.51
x
|
8.21
x
|
12.7
x
|
EV / FCF
|
-1,504
x
|
-56.7
x
|
36.6
x
|
24.4
x
|
242
x
|
-140
x
|
FCF Yield
|
-0.07%
|
-1.76%
|
2.73%
|
4.1%
|
0.41%
|
-0.71%
|
Price to Book
|
3.15
x
|
1.46
x
|
0.98
x
|
2.85
x
|
3.87
x
|
4.4
x
|
Nbr of stocks (in thousands)
|
45,943
|
45,943
|
45,943
|
45,943
|
45,943
|
45,953
|
Reference price
2 |
24.00
|
12.60
|
9.760
|
37.82
|
72.04
|
97.35
|
Announcement Date
|
08/10/18
|
10/09/19
|
07/12/20
|
07/09/21
|
18/08/22
|
28/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,309
|
4,464
|
4,217
|
4,910
|
8,137
|
7,435
|
EBITDA
1 |
135.2
|
166
|
209.5
|
305.8
|
429.9
|
376
|
EBIT
1 |
117.6
|
145.3
|
187.1
|
275.5
|
393.1
|
330.7
|
Operating Margin
|
3.55%
|
3.26%
|
4.44%
|
5.61%
|
4.83%
|
4.45%
|
Earnings before Tax (EBT)
1 |
43.33
|
74.32
|
91.46
|
211.8
|
339.9
|
235.4
|
Net income
1 |
28.56
|
52.15
|
70.23
|
156.5
|
252.6
|
170.4
|
Net margin
|
0.86%
|
1.17%
|
1.67%
|
3.19%
|
3.1%
|
2.29%
|
EPS
2 |
0.7260
|
1.135
|
1.529
|
3.407
|
5.499
|
3.709
|
Free Cash Flow
1 |
-0.9269
|
-15.65
|
21.49
|
81.64
|
14.58
|
-34.1
|
FCF margin
|
-0.03%
|
-0.35%
|
0.51%
|
1.66%
|
0.18%
|
-0.46%
|
FCF Conversion (EBITDA)
|
-
|
-
|
10.25%
|
26.7%
|
3.39%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
30.6%
|
52.15%
|
5.77%
|
-
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.1000
|
0.1500
|
0.2000
|
0.2000
|
Announcement Date
|
08/10/18
|
10/09/19
|
07/12/20
|
07/09/21
|
18/08/22
|
28/08/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
292
|
308
|
338
|
253
|
218
|
299
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.16
x
|
1.856
x
|
1.613
x
|
0.8288
x
|
0.5068
x
|
0.7964
x
|
Free Cash Flow
1 |
-0.93
|
-15.7
|
21.5
|
81.6
|
14.6
|
-34.1
|
ROE (net income / shareholders' equity)
|
10.8%
|
14%
|
16.5%
|
29.4%
|
34.5%
|
18.2%
|
ROA (Net income/ Total Assets)
|
5.13%
|
5.3%
|
6.2%
|
7.17%
|
8.1%
|
6.76%
|
Assets
1 |
556.9
|
984.8
|
1,133
|
2,182
|
3,119
|
2,520
|
Book Value Per Share
2 |
7.630
|
8.620
|
9.940
|
13.30
|
18.60
|
22.10
|
Cash Flow per Share
2 |
0.7000
|
0.2400
|
0.1100
|
0.0700
|
1.060
|
0.7800
|
Capex
1 |
65.5
|
104
|
136
|
72.6
|
152
|
191
|
Capex / Sales
|
1.98%
|
2.32%
|
3.22%
|
1.48%
|
1.87%
|
2.57%
|
Announcement Date
|
08/10/18
|
10/09/19
|
07/12/20
|
07/09/21
|
18/08/22
|
28/08/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.77% | 64.59M | | +22.64% | 69.65B | | -6.69% | 46.9B | | +23.82% | 44.8B | | +30.54% | 27.98B | | +8.59% | 19.58B | | +13.41% | 17.08B | | -11.77% | 15.08B | | -28.13% | 14.52B | | +21.75% | 11.6B |
Other Specialty Chemicals
|